CO5040090A1 - Inhibidores de proteasas - Google Patents
Inhibidores de proteasasInfo
- Publication number
- CO5040090A1 CO5040090A1 CO99036559A CO99036559A CO5040090A1 CO 5040090 A1 CO5040090 A1 CO 5040090A1 CO 99036559 A CO99036559 A CO 99036559A CO 99036559 A CO99036559 A CO 99036559A CO 5040090 A1 CO5040090 A1 CO 5040090A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- group
- cycloalkyl
- het
- alkynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8905698P | 1998-06-12 | 1998-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5040090A1 true CO5040090A1 (es) | 2001-05-29 |
Family
ID=22215426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99036559A CO5040090A1 (es) | 1998-06-12 | 1999-06-10 | Inhibidores de proteasas |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1086083A4 (xx) |
JP (1) | JP2002517485A (xx) |
AR (1) | AR018652A1 (xx) |
AU (1) | AU4564499A (xx) |
CA (1) | CA2334652A1 (xx) |
CO (1) | CO5040090A1 (xx) |
DZ (1) | DZ2815A1 (xx) |
MA (1) | MA24877A1 (xx) |
PE (1) | PE20000725A1 (xx) |
WO (1) | WO1999064399A1 (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001034599A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001034156A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
US6583137B1 (en) | 1999-11-10 | 2003-06-24 | Smithkline Beecham Corporation | Protease inhibitors |
JP2003527429A (ja) | 2000-03-21 | 2003-09-16 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害物質 |
WO2002080920A1 (en) * | 2001-04-06 | 2002-10-17 | Axys Pharmaceuticals, Inc. | Arylacetamido-ketobenzoxazole as cysteine protease inhibitors |
WO2003062192A1 (en) | 2002-01-17 | 2003-07-31 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
EP2240491B1 (en) | 2008-01-09 | 2015-07-15 | Amura Therapeutics Limited | TETRAHYDROFURO(2,3-b)PYRROL-3-ONE DERIVATIVES AS INHIBITORS OF CYSTEINE PROTEINASES |
WO2023041432A1 (en) | 2021-09-14 | 2023-03-23 | Boehringer Ingelheim International Gmbh | 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT74733A (en) * | 1993-11-09 | 1997-02-28 | Merck & Co Inc | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
-
1999
- 1999-06-09 DZ DZ990115A patent/DZ2815A1/xx active
- 1999-06-10 MA MA25619A patent/MA24877A1/fr unknown
- 1999-06-10 AR ARP990102767A patent/AR018652A1/es unknown
- 1999-06-10 CO CO99036559A patent/CO5040090A1/es unknown
- 1999-06-11 WO PCT/US1999/013334 patent/WO1999064399A1/en not_active Application Discontinuation
- 1999-06-11 JP JP2000553408A patent/JP2002517485A/ja not_active Withdrawn
- 1999-06-11 EP EP99928614A patent/EP1086083A4/en not_active Withdrawn
- 1999-06-11 AU AU45644/99A patent/AU4564499A/en not_active Abandoned
- 1999-06-11 CA CA002334652A patent/CA2334652A1/en not_active Abandoned
- 1999-06-11 PE PE1999000518A patent/PE20000725A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4564499A (en) | 1999-12-30 |
MA24877A1 (fr) | 1999-12-31 |
CA2334652A1 (en) | 1999-12-16 |
WO1999064399A1 (en) | 1999-12-16 |
JP2002517485A (ja) | 2002-06-18 |
EP1086083A1 (en) | 2001-03-28 |
DZ2815A1 (fr) | 2003-12-01 |
AR018652A1 (es) | 2001-11-28 |
PE20000725A1 (es) | 2000-09-28 |
EP1086083A4 (en) | 2001-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2196636T3 (es) | Ciclohexenocarboxilatos como inhibidores de la neuraminidasa. | |
EA200400815A1 (ru) | Контролируемый синтез зипразидона и его композиции | |
CO5040090A1 (es) | Inhibidores de proteasas | |
CO5540341A2 (es) | Arilaminas para el tratamiento de condiciones asociadas con gsk-3 | |
CA2318349A1 (en) | Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use | |
DK0915866T3 (da) | Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre | |
DK1075260T3 (da) | Hidtil ukendte fedtsyreanaloger til behandling af sekundær restenose | |
RS54717B1 (en) | PROSTAGLANDIN NITRO OXIDERIVES | |
CO5580746A2 (es) | Derivados de fenil-piperazina como inhibidores de la reabsorcion de la serotonina | |
UY26820A1 (es) | Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra | |
TW200716534A (en) | Novel resorcinol derivatives | |
TR199701254T1 (xx) | 5-HT al�� inhibit�r�n�n selektif 5-HT1A antagonistiyle kombinasyonu. | |
ATE347539T1 (de) | Wässrige harzzusammensetzung | |
AU2479702A (en) | Tripeptidyl peptidase inhibitors | |
HK1094680A1 (en) | Anti-inflammatory agents | |
TW200500806A (en) | Resist composition and patterning process | |
RS50229B (sr) | Analozi vitamina d3 | |
NO944121L (no) | Epoksyravsyrederivater | |
BR0114156A (pt) | Forma amorfa de inibidor de ciclo de célula | |
EP1201641A3 (en) | Composition of vinyl ether group containing (meth)acrylic acid ester and production method thereof | |
CO4970804A1 (es) | Nuevos derivados de la vitamina d3 | |
CO5080758A1 (es) | DERIVADOS DE 3-(2-oxo-[1,3´]BIPIRROLODINIL-3-ILIDENMETIL | |
ATE315026T1 (de) | Amlodipin-hemimaleat | |
EA199700395A1 (ru) | Способ получения ингибиторов протеазы вируса иммунодефицита человека | |
DK0655057T3 (da) | Cyanoguanidiner som kaliumkanalblokkere |